Method for detection of, or the risk of, bladder cancer
US9562905B2 · kind B2 · utility
0Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 29, 2010 |
| Grant date | Feb 7, 2017 |
| Priority date | — |
| Expiry date | Aug 2, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/34
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods for the detection of, or the risk of, bladder cancer in a patient, comprising assaying for the presence of a combination of at least two biomarkers selected from CEA, VEGF, IL-8, NGAL, NSE, IL-2, EGF, TM, d-Dimer, MMP-9, IL-6, IL-4, MMP-9/NGAL, FAS, CRP, TUP and NMP22 in one or more samples isolated from a patient wherein detecting the presence of a combination of at least two biomarkers in the one or more samples indicates the presence or risk of bladder cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.